2.115USD+5.49%Mkt Cap: 75.19M USDP/E: 4.92Last update: 2026-06-01
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men …
Industry Peers
Medical Care FacilitiesIndicators:|
Key Statistics
Company
Market Cap75.19M USD
Enterprise Value171.90M USD
Revenue (TTM)188.16M USD
Gross Profit137.36M USD
Net Income (TTM)27.05M USD
Revenue/Share6.055 USD
Last Price2.115 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees223
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)4.92
P/E (Forward)3.51
PEG—
EV/EBITDA5.23
EV/Revenue0.91
P/S0.38
P/B-1.07
EPS (TTM)0.43
EPS (Forward)0.57
52W Range
1.27024% of range4.750
52W High4.750 USD
52W Low1.270 USD
Profitability
Gross Margin71.46%
Oper. Margin9.78%
EBITDA Margin17.46%
Profit Margin14.07%
ROE-46.20%
ROA25.13%
Growth
Revenue Growth-8.30%
Earnings Growth-83.80%
Cash Flow & Leverage
Operating CF35.19M USD
CapEx (TTM)6.86M USD
FCF Margin-2.52%
FCF Yield-6.29%
Net Debt103.10M USD
Net Debt/EBITDA3.14
Balance Sheet
Debt/Equity-1.88
Current Ratio1.29
Quick Ratio0.45
Book Value/Sh-1.8710 USD
Cash/Share0.1750 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)2.986 USD
Target Range2.000 USD – 4.000 USD
# Analysts5
Ownership
Shares Out.30.33M
Float19.62M
Insiders10.39%
Institutions66.62%
Short Interest
Short Ratio8.2d
Short % Float7.38%
Short % Out.5.35%
Shares Short1.62M
Short (prev mo.)1.69M
Technical
SMA 501.887 (+12.1%)
SMA 2002.451 (-13.7%)
Beta1.71
S&P 52W Chg27.94%
Avg Vol (30d)195.44K
Avg Vol (10d)252.79K
Technical Indicators
RSI (14)48.6
MACD-0.0033
MACD Signal0.0153
MACD Hist.-0.0186
BB Upper2.272 USD
BB Middle2.068 USD
BB Lower1.864 USD
BB Width19.75%
ATR (14)0.1373 USD
Vol Ratio (20d)0.38x